Volume 38, Issue 11 pp. 3554-3566
Research Report
Full Access

Blocking brain-derived neurotrophic factor inhibits injury-induced hyperexcitability of hippocampal CA3 neurons

Raminder Gill

Raminder Gill

Department of Pharmacology & Therapeutics, McGill University, Bellini Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, QC, Canada, H3G 0B1

Search for more papers by this author
Philip K.-Y. Chang

Philip K.-Y. Chang

Department of Pharmacology & Therapeutics, McGill University, Bellini Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, QC, Canada, H3G 0B1

Search for more papers by this author
George A. Prenosil

George A. Prenosil

Department of Pharmacology & Therapeutics, McGill University, Bellini Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, QC, Canada, H3G 0B1

Search for more papers by this author
Emily C. Deane

Emily C. Deane

Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada

Search for more papers by this author
Rebecca A. McKinney

Corresponding Author

Rebecca A. McKinney

Department of Pharmacology & Therapeutics, McGill University, Bellini Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, QC, Canada, H3G 0B1

Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada

Correspondence: Dr Rebecca A. McKinney, Department of Pharmacology & Therapeutics, as above.

E-mail: [email protected]

Search for more papers by this author
First published: 30 September 2013
Citations: 20

Abstract

Brain trauma can disrupt synaptic connections, and this in turn can prompt axons to sprout and form new connections. If these new axonal connections are aberrant, hyperexcitability can result. It has been shown that ablating tropomyosin-related kinase B (TrkB), a receptor for brain-derived neurotrophic factor (BDNF), can reduce axonal sprouting after hippocampal injury. However, it is unknown whether inhibiting BDNF-mediated axonal sprouting will reduce hyperexcitability. Given this, our purpose here was to determine whether pharmacologically blocking BDNF inhibits hyperexcitability after injury-induced axonal sprouting in the hippocampus. To induce injury, we made Schaffer collateral lesions in organotypic hippocampal slice cultures. As reported by others, we observed a 50% reduction in axonal sprouting in cultures treated with a BDNF blocker (TrkB-Fc) 14 days after injury. Furthermore, lesioned cultures treated with TrkB-Fc were less hyperexcitable than lesioned untreated cultures. Using electrophysiology, we observed a two-fold decrease in the number of CA3 neurons that showed bursting responses after lesion with TrkB-Fc treatment, whereas we found no change in intrinsic neuronal firing properties. Finally, evoked field excitatory postsynaptic potential recordings indicated an increase in network activity within area CA3 after lesion, which was prevented with chronic TrkB-Fc treatment. Taken together, our results demonstrate that blocking BDNF attenuates injury-induced hyperexcitability of hippocampal CA3 neurons. Axonal sprouting has been found in patients with post-traumatic epilepsy. Therefore, our data suggest that blocking the BDNF–TrkB signaling cascade shortly after injury may be a potential therapeutic target for the treatment of post-traumatic epilepsy.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.